Quarterly report pursuant to Section 13 or 15(d)

Options Exercisable CelLynx (Details)

v3.5.0.2
Options Exercisable CelLynx (Details) - Cellynx Group Inc. [Member]
9 Months Ended
Sep. 30, 2016
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Beginning, Number of Options | shares 69,000,000
Options, Granted | shares
Options, Cancelled | shares (24,000,000)
Ending,Number of Options, outstanding and exercisable | shares 45,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]  
Weighted Average Exercise Price | $ / shares $ 0.0002
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Cancelled | $ / shares 0.0002
Weighted Average Exercise Price | $ / shares $ 0.0002
Weighted Average Remaining Contractual Life 2 years 2 days
Weighted Average Remaining Contractual Life, forfeited 2 years 2 days
Weighted Average Remaining Contractual Life 1 year 4 months 3 days